These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38004573)

  • 81. MOF-derived nanoporous carbons with diverse tunable nanoarchitectures.
    Kim M; Xin R; Earnshaw J; Tang J; Hill JP; Ashok A; Nanjundan AK; Kim J; Young C; Sugahara Y; Na J; Yamauchi Y
    Nat Protoc; 2022 Dec; 17(12):2990-3027. PubMed ID: 36064756
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Post-Synthetic Modification of ZIF-8 Crystals and Films through UV Light Photoirradiation: Impact on the Physicochemical Behavior of the MOF.
    Papurello RL; Lozano LA; Ramos-Fernández EV; Fernández JL; Zamaro JM
    Chemphyschem; 2019 Dec; 20(23):3201-3209. PubMed ID: 31562667
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
    Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Microfluidic-Assisted ZIF-Silk-Polydopamine Nanoparticles as Promising Drug Carriers for Breast Cancer Therapy.
    Gao Z; Mansor MH; Winder N; Demiral S; Maclnnes J; Zhao X; Muthana M
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37513998
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes.
    Coluccia M; Parisse V; Guglielmi P; Giannini G; Secci D
    Eur J Med Chem; 2022 Dec; 244():114801. PubMed ID: 36215860
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of ZIF-8 MOFs on structure and function of blood components.
    Lin J; Huang L; Ou H; Chen A; Xiang R; Liu Z
    RSC Adv; 2021 Jun; 11(35):21414-21425. PubMed ID: 35478779
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Room temperature fabrication of post-modified zeolitic imidazolate framework-90 as stationary phase for open-tubular capillary electrochromatography.
    Yu LQ; Yang CX; Yan XP
    J Chromatogr A; 2014 May; 1343():188-94. PubMed ID: 24767798
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hierarchical FAU/ZIF-8 Hybrid Materials as Highly Efficient Acid-Base Catalysts for Aldol Condensation.
    Suttipat D; Wannapakdee W; Yutthalekha T; Ittisanronnachai S; Ungpittagul T; Phomphrai K; Bureekaew S; Wattanakit C
    ACS Appl Mater Interfaces; 2018 May; 10(19):16358-16366. PubMed ID: 29676158
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line.
    Yaman Ü; Aslan M; Ozturk S; Ulubayram K; Eroğlu İ
    Pharm Dev Technol; 2020 Dec; 25(10):1192-1203. PubMed ID: 32729757
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hybrid ZIF-8-90 for Selective Solid-Phase Microextraction of Exhaled Breath from Gastric Cancer Patients.
    Ma MY; Yu LQ; Wang SW; Meng Y; Lv YK
    ACS Appl Bio Mater; 2021 Apr; 4(4):3608-3613. PubMed ID: 35014446
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Synthesis of Biocompatible Nanoporous ZIF-8-Gum Arabic as a New Carrier for the Targeted Delivery of Curcumin.
    Khalilian SF; Tohidi M; Rastegari B
    ACS Omega; 2023 Jan; 8(3):3245-3257. PubMed ID: 36713741
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Polymer Matrix Incorporated with ZIF-8 for Application in Nonlinear Optics.
    Mezenov YA; Kulachenkov NK; Yankin AN; Rzhevskiy SS; Alekseevskiy PV; Gilemkhanova VD; Bachinin SV; Dyachuk V; Milichko VA
    Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32481655
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Microfluidic formulation of anticancer peptide loaded ZIF-8 nanoparticles for the treatment of breast cancer.
    Qiu J; Tomeh MA; Jin Y; Zhang B; Zhao X
    J Colloid Interface Sci; 2023 Jul; 642():810-819. PubMed ID: 37043939
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Colloidal metal-organic framework particles: the pioneering case of ZIF-8.
    Troyano J; Carné-Sánchez A; Avci C; Imaz I; Maspoch D
    Chem Soc Rev; 2019 Nov; 48(23):5534-5546. PubMed ID: 31664283
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Tuning the Phase Composition of Metal-Organic Framework Membranes for Helium Separation through Incorporation of Fullerenes.
    Han J; Wu H; Fan H; Ding L; Hai G; Caro J; Wang H
    J Am Chem Soc; 2023 Jul; 145(27):14793-14801. PubMed ID: 37351897
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Sonocrystallization of ZIF-8 on Electrostatic Spinning TiO2 Nanofibers Surface with Enhanced Photocatalysis Property through Synergistic Effect.
    Zeng X; Huang L; Wang C; Wang J; Li J; Luo X
    ACS Appl Mater Interfaces; 2016 Aug; 8(31):20274-82. PubMed ID: 27433886
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Highly efficient Hg
    Zhou J; Zhang H; Xie T; Liu Y; Shen Q; Yang J; Cao L; Yang J
    J Environ Sci (China); 2022 Sep; 119():33-43. PubMed ID: 35934463
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Preparation of reduced graphite oxide loaded with cobalt(II) and nitrogen co-doped carbon polyhedrons from a metal-organic framework (type ZIF-67), and its application to electrochemical determination of metronidazole.
    Chen H; Wu X; Zhao R; Zheng Z; Yuan Q; Dong Z; Gan W
    Mikrochim Acta; 2019 Aug; 186(9):623. PubMed ID: 31414250
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Synthesis and Characterization of ZIF-90 Nanoparticles as Potential Brain Cancer Therapy.
    Monarca L; Ragonese F; Sabbatini P; Caglioti C; Stamegna M; Palazzetti F; Sportoletti P; Costantino F; Fioretti B
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.